Medicines Development for Global Health (MDGH) announced today that the Ghana Food and Drugs Authority (FDA) approved moxidectin 2 mg oral tables for the treatment of river blindness (onchocerciasis) in adults and children aged 4 years and older.
December 5, 2024
October 16, 2024
June 21, 2024
June 18, 2024
May 14, 2024
February 12, 2024
December 22, 2023
December 21, 2023
November 30, 2023
November 29, 2023
November 3, 2023
October 20, 2023
October 19, 2023
August 9, 2023
August 2, 2023
Please try again.
Find what you need to help spread the word about new and improved treatments for neglected diseases